BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saponaro C, Vagheggini A, Scarpi E, Centonze M, Catacchio I, Popescu O, Pastena MI, Giotta F, Silvestris N, Mangia A. NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma. J Exp Clin Cancer Res 2018;37:96. [PMID: 29716631 DOI: 10.1186/s13046-018-0766-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Saponaro C, Fanizzi A, Sonnessa M, Mondelli P, Vergara D, Loisi D, Massafra R, Latorre A, Zito FA, Schirosi L. Downstream Signaling of Inflammasome Pathway Affects Patients’ Outcome in the Context of Distinct Molecular Breast Cancer Subtypes. Pharmaceuticals 2022;15:651. [DOI: 10.3390/ph15060651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Leng X, Huang G, Ma F, Ding J. Correlation between the characteristics of ultrasonic contrast and the regional distribution of tumor vascular heterogeneity in breast cancer. Food Sci Technol 2022;42:e40320. [DOI: 10.1590/fst.40320] [Reference Citation Analysis]
3 Saponaro C, Scarpi E, Sonnessa M, Cioffi A, Buccino F, Giotta F, Pastena MI, Zito FA, Mangia A. Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients. Front Oncol 2021;11:705331. [PMID: 34540671 DOI: 10.3389/fonc.2021.705331] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 Kawase A, Hirosoko M, Sugihara Y, Koyama Y, Fukae A, Shimada H, Iwaki M. NHERF1/EBP50 as a Target for Modulation of MRP Function in HepG2 Cells. Pharmaceuticals (Basel) 2021;14:239. [PMID: 33800412 DOI: 10.3390/ph14030239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sonnessa M, Cioffi A, Brunetti O, Silvestris N, Zito FA, Saponaro C, Mangia A. NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer. Front Oncol 2020;10:1587. [PMID: 33014808 DOI: 10.3389/fonc.2020.01587] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
6 Zhang J, Zhang S, Gao S, Ma Y, Tan X, Kang Y, Ren W. HIF-1α, TWIST-1 and ITGB-1, associated with Tumor Stiffness, as Novel Predictive Markers for the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer. Cancer Manag Res 2020;12:2209-22. [PMID: 32273760 DOI: 10.2147/CMAR.S246349] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
7 Guo Y, Fan Y, Pei X. Fangjihuangqi Decoction inhibits MDA-MB-231 cell invasion in vitro and decreases tumor growth and metastasis in triple-negative breast cancer xenografts tumor zebrafish model. Cancer Med 2020;9:2564-78. [PMID: 32037729 DOI: 10.1002/cam4.2894] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
8 Harguindey S, Alfarouk K, Orozco JP, Hardonniere K, Stanciu D, Fais S, Devesa J. A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics. Int J Mol Sci 2020;21:E1110. [PMID: 32046158 DOI: 10.3390/ijms21031110] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
9 Bushau-Sprinkle AM, Lederer ED. New roles of the Na+/H+ exchange regulatory factor 1 scaffolding protein: a review. Am J Physiol Renal Physiol 2020;318:F804-8. [PMID: 31984791 DOI: 10.1152/ajprenal.00467.2019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Schirosi L, Saponaro C, Giotta F, Popescu O, Pastena MI, Scarpi E, Mangia A. Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients. Transl Oncol 2020;13:186-92. [PMID: 31865181 DOI: 10.1016/j.tranon.2019.10.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
11 Mangia A, Saponaro C, Vagheggini A, Opinto G, Centonze M, Vicenti C, Popescu O, Pastena M, Giotta F, Silvestris N. Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients? Cancers (Basel) 2019;11:E1393. [PMID: 31540486 DOI: 10.3390/cancers11091393] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
12 Saponaro C, Scarpi E, Zito FA, Giotta F, Silvestris N, Mangia A. Independent Negative Prognostic Role of TCF1 Expression within the Wnt/β-Catenin Signaling Pathway in Primary Breast Cancer Patients. Cancers (Basel) 2019;11:E1035. [PMID: 31336689 DOI: 10.3390/cancers11071035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
13 Catacchio I, Silvestris N, Scarpi E, Schirosi L, Scattone A, Mangia A. Intratumoral, rather than stromal, CD8+ T cells could be a potential negative prognostic marker in invasive breast cancer patients. Transl Oncol 2019;12:585-95. [PMID: 30682679 DOI: 10.1016/j.tranon.2018.12.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]